Company profile TENX

Tenax Therapeutics Inc
tenax therapeutics is focused on developing and commercializing pharmaceutical products that improve outcomes for patients who require treatment for various critical care conditions. our development portfolio includes novel product candidates that have the potential to address various critical care conditions with high unmet medical need.
Quarter analysis & expected interestLast update: February 09 2024 20:35:23.

After 39 days of this quarter the interest is at 30.0. Based on that we can calculate that during remaining 52 days it will total up to 70.0.
Tenax Therapeutics expected interest is significantly lower compared to previous quarter (-68.2%) and same quarter last year (-49.3%).

YearQ1Q2Q3Q4
2019169
57
-66.3% QoQ
187
228.1% QoQ
152
-18.7% QoQ
2020 153
-9.5% YoY 0.7% QoQ
172
201.8% YoY 12.4% QoQ
174
-7.0% YoY 1.2% QoQ
179
17.8% YoY 2.9% QoQ
2021 154
0.7% YoY -14.0% QoQ
68
-60.5% YoY -55.8% QoQ
108
-37.9% YoY 58.8% QoQ
89
-50.3% YoY -17.6% QoQ
2022 135
-12.3% YoY 51.7% QoQ
168
147.1% YoY 24.4% QoQ
125
15.7% YoY -25.6% QoQ
62
-30.3% YoY -50.4% QoQ
2023 138
2.2% YoY 122.6% QoQ
154
-8.3% YoY 11.6% QoQ
67
-46.4% YoY -56.5% QoQ
220
254.8% YoY 228.4% QoQ
2024 30
-78.3% YoY -86.4% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Tenax Therapeutics search interestLast update: February 09 2024 20:35:23.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 20:35:25.

The average 5 years interest of Tenax Therapeutics was 10.58 per week.
The last year interest of Tenax Therapeutics compared to the last 5 years has changed by 2.84%.
This is something to be checked.
The last year interest is comparable to 5 years ago. It has changed only by -13.1%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics stock price to provide analysis

Correlation between past revenue and Tenax Therapeutics stock price search interest

There is not enough data for Tenax Therapeutics stock price to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics stock price to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interestLast update: February 09 2024 20:35:34.

After 39 days of this quarter the interest is at 0.0. Based on that we can calculate that during remaining 52 days it will total up to 0.0.
Tenax Therapeutics news expected interest is significantly lower compared to previous quarter (-100.0%) and same quarter last year (-100.0%).

YearQ1Q2Q3Q4
2019116
170
46.6% QoQ
83
-51.2% QoQ
31
-62.7% QoQ
2020 26
-77.6% YoY -16.1% QoQ
82
-51.8% YoY 215.4% QoQ
27
-67.5% YoY -67.1% QoQ
50
61.3% YoY 85.2% QoQ
2021 56
115.4% YoY 12.0% QoQ
86
4.9% YoY 53.6% QoQ
57
111.1% YoY -33.7% QoQ
0
-100.0% YoY -100.0% QoQ
2022 0
-100.0% YoY -100.0% QoQ
10
-88.4% YoY inf% QoQ
0
-100.0% YoY -100.0% QoQ
99
inf% YoY inf% QoQ
2023 47
inf% YoY -52.5% QoQ
87
770.0% YoY 85.1% QoQ
76
inf% YoY -12.6% QoQ
40
-59.6% YoY -47.4% QoQ
2024 0
-100.0% YoY -100.0% QoQ
- - -
this symbol represents interest this quarter up to now and updates daily. For expected interest by the end of the quarter based on current trend see "Quarter analysis" above the table.
Correlation between past revenue and Tenax Therapeutics news search interestLast update: February 09 2024 20:35:33.
Correlation coefficient between keyword and revenue is nan
Interest value is multiplied to fit the chart properly. Correlation level is represented by Pearson correlation coefficient. Value closer to 1 represents higher level of correlation. Value closer to -1 represents inverted relationship. Value closer to 0 represents no relationship.
Analysis of YoY 5Y Google Trends Last update: February 09 2024 20:35:35.

The average 5 years interest of Tenax Therapeutics news was 4.38 per week.
The last year interest of Tenax Therapeutics news compared to the last 5 years has changed by -6.39%.
This is something to be checked.
The last year interest is quite lower compared to 5 years ago. It has decreased by -46.68%.

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics pulmonary arterial hypertension to provide analysis

Correlation between past revenue and Tenax Therapeutics pulmonary arterial hypertension search interest

There is not enough data for Tenax Therapeutics pulmonary arterial hypertension to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics pulmonary arterial hypertension to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics clinical trials to provide analysis

Correlation between past revenue and Tenax Therapeutics clinical trials search interest

There is not enough data for Tenax Therapeutics clinical trials to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics clinical trials to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics imatinib to provide analysis

Correlation between past revenue and Tenax Therapeutics imatinib search interest

There is not enough data for Tenax Therapeutics imatinib to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics imatinib to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics TNX-201 to provide analysis

Correlation between past revenue and Tenax Therapeutics TNX-201 search interest

There is not enough data for Tenax Therapeutics TNX-201 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics TNX-201 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics TNX-101 to provide analysis

Correlation between past revenue and Tenax Therapeutics TNX-101 search interest

There is not enough data for Tenax Therapeutics TNX-101 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics TNX-101 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics TNX-102 to provide analysis

Correlation between past revenue and Tenax Therapeutics TNX-102 search interest

There is not enough data for Tenax Therapeutics TNX-102 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics TNX-102 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Quarter analysis & expected interest

There is not enough data for Tenax Therapeutics TNX-103 to provide analysis

Correlation between past revenue and Tenax Therapeutics TNX-103 search interest

There is not enough data for Tenax Therapeutics TNX-103 to provide correlation calculation

Analysis of YoY 5Y Google Trends

There is not enough data for Tenax Therapeutics TNX-103 to provide analysis

Google Trends widget for keyword preview might not work in your browser. If so, try Google Chrome
Useful links and data for TENX
Earnings date: 2024-03-28 After close
Company name: Tenax Therapeutics Inc
Sector: Professional, Scientific, and Technical Services
Company's website
Hypercharts
Yahoo Finance
MarketWatch
StockTwits
SEC Filings
SwaggyStocks
Latest articles

2026-09-01T04:00:00-07:00

GlobeNewswire
Tenax Therapeutics to Participate in the 2026 Cantor Global Healthcare Conference

2026-08-31T12:55:57.269173359Z

Analyst Upgrades
Guggenheim Downgrades Tenax Therapeutics to Neutral

2026-08-29T05:21:22-07:00

GlobeNewswire
Tenax Therapeutics Announces Presentation of Phase 3 LEVEL Results in Late-Breaking Scientific Sessions at ESC Congress 2026

2026-08-19T13:12:00-04:00

PR Newswire
Tenax Therapeutics (TENX) Securities Investigation Notice - Levi & Korsinsky

2026-08-16T21:38:00Z

BusinessWire
TENX Investors Have Opportunity to Join Tenax Therapeutics, Inc. Fraud Investigation with SBS Law

2026-08-12T19:11:00-04:00

PR Newswire
Tenax Therapeutics Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into Tenax Therapeutics (TENX)

2026-08-11T16:02:35.891979949Z

Analyst Upgrades
Chardan Capital Downgrades Tenax Therapeutics to Neutral, Lowers Price Target to $5

2026-08-11T14:19:33.444537631Z

Analyst Upgrades
Guggenheim Maintains Buy on Tenax Therapeutics, Lowers Price Target to $4

2026-08-11T12:38:53.968934238Z

Analyst Upgrades
Evercore ISI Group Downgrades Tenax Therapeutics to In-Line, Lowers Price Target to $5

2026-08-10T20:30:51.374133113Z

Analyst Upgrades
William Blair Downgrades Tenax Therapeutics to Market Perform

2026-08-10T04:00:00-07:00

GlobeNewswire
Tenax Therapeutics Announces Topline Results from Phase 3 LEVEL Clinical Trial of TNX-103 in Patients with PH-HFpEF

2026-07-31T04:00:00-07:00

GlobeNewswire
Tenax Therapeutics Reports Second Quarter 2026 Financial Results and Provides Corporate Update

2026-07-28T13:14:13.638698324Z

Analyst Upgrades
Canaccord Genuity Initiates Coverage On Tenax Therapeutics with Buy Rating, Announces Price Target of $35

2026-07-22T14:59:09.765810241Z

Analyst Upgrades
Evercore ISI Group Initiates Coverage On Tenax Therapeutics with Outperform Rating, Announces Price Target of $39

2026-07-02T13:05:00-07:00

GlobeNewswire
Tenax Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)